BE855357A - Nouveau medicament immunostimulant et son procede de preparation - Google Patents

Nouveau medicament immunostimulant et son procede de preparation

Info

Publication number
BE855357A
BE855357A BE178163A BE178163A BE855357A BE 855357 A BE855357 A BE 855357A BE 178163 A BE178163 A BE 178163A BE 178163 A BE178163 A BE 178163A BE 855357 A BE855357 A BE 855357A
Authority
BE
Belgium
Prior art keywords
preparation
medicinal product
immunostimulant
new
new immunostimulant
Prior art date
Application number
BE178163A
Other languages
English (en)
French (fr)
Original Assignee
Merieux Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merieux Inst filed Critical Merieux Inst
Publication of BE855357A publication Critical patent/BE855357A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
BE178163A 1976-06-04 1977-06-03 Nouveau medicament immunostimulant et son procede de preparation BE855357A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7616937A FR2374042A1 (fr) 1976-06-04 1976-06-04 Nouveau medicament immunostimulant et son procede de preparation

Publications (1)

Publication Number Publication Date
BE855357A true BE855357A (fr) 1977-12-05

Family

ID=9174007

Family Applications (1)

Application Number Title Priority Date Filing Date
BE178163A BE855357A (fr) 1976-06-04 1977-06-03 Nouveau medicament immunostimulant et son procede de preparation

Country Status (7)

Country Link
US (2) US4182751A (cs)
BE (1) BE855357A (cs)
CA (1) CA1091582A (cs)
DE (1) DE2725204C2 (cs)
FR (1) FR2374042A1 (cs)
GB (1) GB1583889A (cs)
NL (1) NL7706174A (cs)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2447193A1 (fr) * 1979-01-25 1980-08-22 Unicler Utilisation de pichia ou d'extraits de pichia, comme medicament.
FR2451923A1 (fr) * 1979-03-22 1980-10-17 Roussel Uclaf Nouveaux derives steroides 7-alkyles, leur procede de preparation et leur application comme medicament
DK138379A (da) * 1979-04-04 1980-10-05 Nordisk Droge & Kemikalie Vaccine imod pleuropneumonia (ondartet lungesyge) hos svin dens anvendelse samt fremgangsmaade og substat til dyrkning specielt aerob fermentering af mikroorganismen haemophilus pleuropneumoniae
WO1981001102A1 (fr) * 1979-10-19 1981-04-30 A Romano Remede pour le traitement des infections virales de l'oeil et d'autres organes
FR2477416A1 (fr) * 1980-03-10 1981-09-11 Unicler Utilisation de hansenula ou d'extraits de hansenula, comme medicament
JPS56135159A (en) 1980-03-26 1981-10-22 Fujirebio Inc Immunological diagnosis method
FR2502496A2 (fr) * 1981-03-30 1982-10-01 Pasteur Institut Fractions nouvelles extraites de bacteries aerobies, douees de proprietes antitumorales, antibacteriennes et inductrices d'interferon, et leur procede de preparation
US4479935A (en) * 1980-04-22 1984-10-30 Institut Pasteur Fractions extracted from aerobic bacteria, endowed with antitumoral, antibacterial and interferon inducing properties, and process for their preparation
FR2480604A1 (fr) * 1980-04-22 1981-10-23 Pasteur Institut Fractions nouvelles extraites de bacteries aerobies, douees de proprietes antitumorales, antibacteriennes et inductrices d'interferon et leur procede de preparation
EP0196530A3 (de) * 1985-03-26 1989-03-22 CTA Finanz AG Mittel und Verfahren zur Beschleunigung des Wachstums, zur Optimierung der Fruchtbarkeit und zur Stimulierung des Immunsystems bei Mensch und Tier
EP0220308A1 (en) * 1985-04-30 1987-05-06 Scripps Clinic And Research Foundation Acute phase protein modulating endotoxic activity of lipopolysaccharides, compositions and methods
US4681761A (en) * 1985-10-24 1987-07-21 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Major iron-regulated protein of Neisseria gonorrhoeae and its use as vaccine
DE3728367C1 (de) * 1987-08-25 1988-09-01 Burkhard Steglich Mittel zur Immunisierung des menschlichen Koerpers bei HIV-Infektionen
US5223491A (en) * 1989-11-09 1993-06-29 Donzis Byron A Method for revitalizing skin by applying topically water insoluble glucan
EP0595209A3 (en) * 1992-10-23 1996-07-17 R I T A Corp An Illinois Corp Cosmetic composition
US5853738A (en) * 1995-10-30 1998-12-29 Dynagen, Inc. Methods for treatment of human immunodeficiency virus infection with pseudomonas phosphoaminolipid extract
US5851534A (en) * 1996-05-03 1998-12-22 Dynagen, Inc. Methods for prevention and/or treatment of neutropenia
WO1998043655A1 (en) * 1997-04-02 1998-10-08 Bioniche Inc. Use of bacterial cell wall extracts for treating topical disorders and wounds
US6183756B1 (en) 1997-05-01 2001-02-06 Dynagen, Inc. Methods for prevention and/or treatment of thrombocytopenia
WO1999007383A1 (en) 1997-08-05 1999-02-18 Bioniche Inc. Composition and method for regulating cell proliferation and cell death
ES2288883T3 (es) * 1999-12-13 2008-02-01 Bioniche Life Sciences Inc. Oligonucleotidos sinteticos utiles terapeuticamente.
NZ520312A (en) * 1999-12-28 2003-08-29 Bioniche Life Sciences Inc Hyaluronic acid in the treatment of cancer
RU2168334C1 (ru) * 2000-02-08 2001-06-10 Предприятие по производству бакпрепаратов научно-исследовательского института эпидемиологии и микробиологии им. Н.Ф. Гамалеи РАМН Способ получения пирогенала
RU2180571C1 (ru) * 2000-09-25 2002-03-20 Самойленко Игорь Иннокентьевич Способ устранения пирогенности пирогенала при сохранении его иммуностимулирующей активности
US7491517B2 (en) * 2006-07-19 2009-02-17 Jeeri R Reddy Method of producing meningococcal meningitis vaccine for Neisseria meningitidis serotypes A,C,Y, and W-135
CN104370997B (zh) * 2014-09-24 2018-07-31 陈辉 去除生物制品中细菌内毒素的试剂盒、方法及其生物制品的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1621118A (en) * 1925-11-04 1927-03-15 Winford P Larson Modified bacteria and toxins, immunizing serums and method of producing them
US1621119A (en) * 1926-01-27 1927-03-15 Winford P Larson Scarlet fever antigen
US2020647A (en) * 1933-06-07 1935-11-12 Hunwicke Roderick Francis Method of manufacturing bacterial solutions
NL63957C (cs) * 1946-01-03
US3148120A (en) * 1952-01-24 1964-09-08 Wander Ag Dr A Hot aqueous phenol extraction of gramnegative bacterial lipopolysaccharides
GB725938A (en) * 1952-01-24 1955-03-16 Wander A G A Method of preparing substantially protein-free polysaccharides from micro-organisms
DE1175389B (de) * 1958-07-26 1964-08-06 Wander Ag Dr A Verfahren zur Herstellung stabiler, waessriger Lipoid-Dispersionen
GB1056839A (en) * 1963-09-19 1967-02-01 Johnson & Johnson Brucella antigen
GB1073694A (en) * 1965-05-24 1967-06-28 Twyford Lab Ltd Preparation of bacterial lipopolysaccharides
US3483290A (en) * 1967-10-24 1969-12-09 Carter Wallace Bacterial fractions
US3636192A (en) * 1970-01-13 1972-01-18 Us Army Meningococcal polysaccharide vaccines
US3859434A (en) * 1973-01-08 1975-01-07 Canadian Patents Dev Meningococcal antigens
CA1020460A (en) * 1973-02-23 1977-11-08 Wellcome Foundation Limited (The) Isolation of immunostimulating glycopeptide from bacteria
FR2269961B1 (cs) * 1974-05-06 1978-03-24 Anvar

Also Published As

Publication number Publication date
FR2374042B1 (cs) 1980-04-30
US4337243A (en) 1982-06-29
US4182751A (en) 1980-01-08
DE2725204C2 (de) 1982-03-04
FR2374042A1 (fr) 1978-07-13
DE2725204A1 (de) 1977-12-22
GB1583889A (en) 1981-02-04
CA1091582A (fr) 1980-12-16
NL7706174A (nl) 1977-12-06

Similar Documents

Publication Publication Date Title
BE855357A (fr) Nouveau medicament immunostimulant et son procede de preparation
FR2352544A1 (fr) Nouveau medicament pour opacification barytee et procede de preparation de ce nouveau medicament
FR2283690A1 (fr) Nouveaux composes tetracycliques utiles comme medicaments et leur procede de preparation
FR2275450A1 (fr) Nouveau derive d'arylthiopentanone, et son procede de preparation
LU77557A1 (fr) Nouveau 2-deoxystreptamine-aminoglycoside,son procede de preparation et medicament le contenant
BE828430A (fr) Phenylalcoylamines, leur procede d'obtention et leur application commemedicaments
BE860614A (fr) Hydroxylamines alkylees, leur procede de preparation et leur emploi comme medicaments
FR2282893A1 (fr) Derives de thienothiazine utiles en tant que medicaments et leur procede de preparation
FR2346324A1 (fr) Nouvelles amidino-urees, procede pour leur preparation et medicaments les renfermant
BE870564A (fr) Nouveau materiau particulaire, sa preparation et son application, notamment comme medicament
BE826982A (fr) Medicament en vue d'eviter les symptomes uremiques et son procede de preparation
FR2351996A1 (fr) Composes 9-(3,5-di-o-acyl-b-d-arabinofuranosyl)-adeniniques, leur procede de preparation et leur application en tant que medicaments
FR2347933A1 (fr) Vaccin antirabique et son procede de preparation
FR2340330A1 (fr) Acides polyvinylbenzenesulfoniques, leur procede de preparation et leur application en tant que medicaments
BE825623A (fr) Nouvelles cephalosporines, leur procede de preparation et medicament les contenent
FR2318652A1 (fr) Nouveau vaccin anti-rabique et son procede de preparation
FR2351993A1 (fr) Composes 9-(3-o-acyl-b-d-arabinofuranosyl)adeniniques, composes 9-(2,3-di-o-acyl-b-d-arabinofuranosyl)-adeniniques, leur procede de preparation, et leur application en tant que medicaments
FR2351995A1 (fr) Composes 9-(2-o-acyl-b-d-arabinofuranosyl)-adeniniques, leur procede de preparation et leur application en tant que medicaments
FR2334345A1 (fr) Nouveau derive d'alcool benzylique, son procede de preparation et medicament le contenant
FR2454804B1 (fr) Medicament a base de dihydroergotoxine et son procede de preparation
BE880615A (fr) Nouveau derive du paracetamol, son procede de preparation et son utilisation en therapeutique
FR2295749A1 (fr) Nouveaux medicaments antiarythmiques et procede de leur preparation
FR2284595A1 (fr) Procede de preparation de nicotinamide et d'isonicotinamide
FR2340316A1 (fr) Nouveau sel de piperazinyluracile, son procede de preparation et medicaments le contenant
FR2351994A1 (fr) Composes 9-(5-o-acyl-b-d-arabinofuranosyl)-adeniniques, procede pour leur preparation et application en tant que medicaments

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: INSTITUT MERIEUX

Effective date: 19890630